Outro raises $7M seed
Announced 8 October 2026
◆ The Round
Outro raised $7M in seed funding, announced on 8 October 2026, led by Listen Ventures, Cake Ventures, LAUNCH, Actions Capital, with participation from Hannah Grey Ventures, SemperVirens, Brock Recovery Group, Pave Health Ventures. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Outro
A New York-based healthcare company providing a specialized deprescribing platform to help patients safely discontinue psychiatric medications. Outro is based in United States and currently at seed stage, operating in Digital Health.
◆ Investors
LeadListen Ventures, Cake Ventures, LAUNCH, Actions Capital
ParticipationHannah Grey Ventures, SemperVirens, Brock Recovery Group, Pave Health Ventures
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Outro's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Outro raise?
Outro raised $7M in its seed round, announced 2026-10-08.
Who invested in Outro's seed round?
The round was led by Listen Ventures, Cake Ventures, LAUNCH and Actions Capital, with participation from Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures.
What does Outro do?
A New York-based healthcare company providing a specialized deprescribing platform to help patients safely discontinue psychiatric medications.
Verified 12 October 2026 · Sources: public filings